Zhe Chen
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 7
-
- Computational Drug Discovery Methods 6
- Molecular Biology top 10%
- Retinoids in leukemia and cellular processes 5
- Natural product bioactivities and synthesis 5
- PI3K/AKT/mTOR signaling in cancer 4
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 7
-
- Cytokine Signaling Pathways and Interactions 7
-
- Hepatitis B Virus Studies 6
-
- Cancer Mechanisms and Therapy 6
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Zhe Chen
81 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Complementary and alternative medicine 202
- Pharmacology 212
- Computational Theory and Mathematics 380
- Molecular Biology 1.2k
- Pharmacology 235
Countries citing papers authored by Zhe Chen
This map shows the geographic impact of Zhe Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Chen more than expected).
Fields of papers citing papers by Zhe Chen
This network shows the impact of papers produced by Zhe Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Chen. The network helps show where Zhe Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhe Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 10 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 11 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 142 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 24 | |
| 15 | 2020 | 1 | |
| 16 | 2017 | 24 | |
| 17 | 2017 | 162 | |
| 18 | Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeuticsbreakdown → | 2017 | 418 |
| 19 | 2016 | 18 | |
| 20 | 2011 | 10 |
About Zhe Chen
Zhe Chen is a scholar working on Hepatology, Molecular Biology and Complementary and alternative medicine, having authored 83 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Computational Drug Discovery Methods (6 papers), Hepatitis B Virus Studies (6 papers), Cancer Mechanisms and Therapy (6 papers), Retinoids in leukemia and cellular processes (5 papers), Natural product bioactivities and synthesis (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Complementary and alternative medicine (202 citations), Pharmacology (212 citations) and Computational Theory and Mathematics (380 citations). Zhe Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lawrence H. Lash, Yu Chen, Qin Chu, Li Fu, Xian Zeng, Peng Zhang, Feng Zhu, Lin Tao, Yinghong Li and Zhongjun Ma. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.